Renal replacement therapy after cardiac surgery; renal function recovers. (October 2013)

• Record Type: Journal Article
• Authors: Steinthorsdottir, Kristin Julia; Kandler, Kristian; Agerlin Windeløv, Nis; Steinbrüchel, Daniel Andreas
• Is Part Of: Scandinavian cardiovascular journal. Volume 47:Number 5(2013:Oct.)
• Page Start: 303
• Page End: 306
• Publication Date: 2013-10
• Subjects: Cardiovascular system -- Diseases -- Periodicals; 617.41
• DOI: 10.3109/14017431.2013.821625
• Languages: English
• ISSNs: 1401-7431

Abstract

<abstract> <title>Abstract</title> <p> <italic>Objectives.</italic> To assess renal outcome in patients discharged from hospital following cardiac surgery-associated acute kidney injury (CSA-AKI) with need for renal replacement therapy. <italic>Design.</italic> In April 2012 we conducted a cross-sectional study of patients treated with renal replacement therapy following cardiac surgery during 2008–2010. We included all adult patients with a pre-operative serum creatinine (sCr) &lt; 200 μM, surviving to discharge. Primary endpoint was use of renal replacement therapy after hospital discharge; secondary endpoint was a sCr &gt; 200 μM at the time of follow-up. <italic>Results.</italic> We reviewed the records of 3828 patients receiving cardiac surgery in the defined period. A total of 107 adult patients with sCr concentrations &lt; 200 μM were treated with post-operative renal replacement therapy of whom 70 survived to discharge. Fifty-six patients were alive at follow-up and none had required renal replacement therapy after initial discharge. Median sCr concentration at follow-up was 111 [56–257] μM and two patients had sCr above 200 μM. <italic>Conclusions</italic>. In this study, renal function recovered in patients discharged from hospital following renal replacement therapy after CSA-AKI. No patients needed further renal replacement therapy and only two (4%) had a sCr &gt; 200 μM at follow-up.</p> </abstract>